Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in drugs

Going Beyond Generics

The generic business for Indian pharma companies has become very large, but now the industry is going through a series of challenges

Read More

Is It The End Of Pharma’s Dream Run?

Unless the Indian pharma industry — not long ago touted as the pharmacy of the world — strives to be more than just a plain generics player

Read More

No Price Change In 78% Of Actively Used Drugs Post GST: NPPA

The National Pharmaceutical Pricing Authority (NPPA) has already announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotics, with a majority being reduced ahead of the GST implementation.

Read More

Affordable Health

Prime Minister Narendra Modi mused recently that the pharmaceutical and medical device industries were upset with his government’s decision to bring down the price of cardiac stents and other healthcare products, including drugs

Read More

Glenmark Stock Up After US Approval To Its Savella Generic

Shares of drug maker Glenmark Pharmaceuticals rose 0.52 per cent to Rs 868. 45 a unit on BSE on Friday, a day that saw the benchmark Sensex down by at least 50 points

Read More

EU Recommends Suspending Hundreds Of Drugs Tested By Indian Firm Micro Therapeutic

Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs

Read More

US Bans Divi's Factory, Shares Hit 3-year Low

US health regulators have banned a drug production site in India belonging to Divi's Laboratories Ltd due to manufacturing violations, sending the company's shares down to a near three-year low on Wednesday

Read More

Sun Pharma Says FDA To Lift Ban On Mohali Drug Plant

Sun Pharmaceutical Industries said on Tuesday that US regulators plan to lift a ban on its Mohali plant in Punjab, allowing the company to restart supplies from there after four years

Read More

Glenmark, Evestra To Jointly Develop And Sell NuvaRing Copy In US

Drug maker Glenmark and Evestra Inc, a San Antonio-based biopharmaceutical research and development company with focus in women’s healthcare, have signed a licensing and commercialization agreement for development and marketing of a generic version of Merck & Co.’s NuvaRing, for the US market

Read More

Sun Pharma Q3 Profit Falls Nearly 5%; Below Estimates

Sun's net profit for the October-December period fell to Rs 1,472 crore from Rs 1,545 crore a year earlier

Read More

Lupin Q3 Profit Up 21%, Beats Estimate

Lupin Ltd reported a 21 per cent jump in its quarterly profit, beating analysts' estimates, helped by higher sales of its diabetes products in the United States

Read More

Pharma Industry Wants Budget To Offer Tax Clarity

The pharmaceutical industry has asked the government to bring in more clarity in terms of tax structure and provide incentives on research and development as part of its budget wish-list

Read More

US FDA Finds Quality Control Problems At Sun Pharma's Halol Plant

The US Food and Drug Administration has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows

Read More

Drugmaker Laurus Labs' Up To Rs 1,332 Crore IPO Fully Subscribed

Laurus Labs' initial public offering of shares to raise up to Rs 1,332 crore was fully subscribed on the last day of the sale on Thursday, stock exchange data showed.

Read More

Sun Pharma Says US Finds More Concerns At Halol Plant

Sun Pharmaceutical Industries said on Wednesday the US health regulator has informed the company of more concerns found at its Halol manufacturing plant after a recent inspection

Read More